Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 7
1973 6
1974 6
1975 3
1976 6
1977 6
1978 1
1979 6
1980 4
1981 15
1982 9
1983 10
1984 5
1985 9
1986 11
1987 11
1988 8
1989 15
1990 9
1991 10
1992 7
1993 6
1994 12
1995 14
1996 22
1997 14
1998 16
1999 19
2000 18
2001 23
2002 16
2003 23
2004 20
2005 27
2006 25
2007 17
2008 29
2009 23
2010 21
2011 36
2012 28
2013 16
2014 15
2015 19
2016 17
2017 19
2018 16
2019 10
2020 9
2021 11
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Results by year

Filters applied: . Clear all
Page 1
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Among authors: parving hh. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
Gæde P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving HH, Pedersen O. Gæde P, et al. Among authors: parving hh. Diabetologia. 2016 Nov;59(11):2298-2307. doi: 10.1007/s00125-016-4065-6. Epub 2016 Aug 16. Diabetologia. 2016. PMID: 27531506 Free PMC article. Clinical Trial.
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.
de Zeeuw D, Anzalone DA, Cain VA, Cressman MD, Heerspink HJ, Molitoris BA, Monyak JT, Parving HH, Remuzzi G, Sowers JR, Vidt DG. de Zeeuw D, et al. Among authors: parving hh. Lancet Diabetes Endocrinol. 2015 Mar;3(3):181-90. doi: 10.1016/S2213-8587(14)70246-3. Epub 2015 Feb 4. Lancet Diabetes Endocrinol. 2015. PMID: 25660356 Clinical Trial.
Diabetic nephropathy.
Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH; American Diabetes Association. Molitch ME, et al. Among authors: parving hh. Diabetes Care. 2003 Jan;26 Suppl 1:S94-8. doi: 10.2337/diacare.26.2007.s94. Diabetes Care. 2003. PMID: 12502629 No abstract available.
PROactive study.
Gaede P, Parving HH, Pedersen O. Gaede P, et al. Among authors: parving hh. Lancet. 2006 Jan 7;367(9504):23-4; author reply 26-7. doi: 10.1016/S0140-6736(06)67912-9. Lancet. 2006. PMID: 16399142 No abstract available.
Genetics of diabetic nephropathy.
Parving HH, Tarnow L, Rossing P. Parving HH, et al. J Am Soc Nephrol. 1996 Dec;7(12):2509-17. doi: 10.1681/ASN.V7122509. J Am Soc Nephrol. 1996. PMID: 8989728 Review.
668 results